Johnson Matthey (LON:JMAT) Insider Andrew Cosslett Purchases 5,136 Shares

Johnson Matthey PLC (LON:JMAT) insider Andrew Cosslett bought 5,136 shares of the stock in a transaction on Tuesday, February 24th. The stock was purchased at an average cost of GBX 1,937 per share, with a total value of £99,484.32.

Johnson Matthey Trading Up 3.2%

Shares of LON JMAT opened at GBX 2,022 on Wednesday. The company’s fifty day moving average is GBX 2,271.33 and its 200-day moving average is GBX 2,100.04. The stock has a market cap of £3.39 billion, a price-to-earnings ratio of -30.68, a P/E/G ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a twelve month low of GBX 1,131 and a twelve month high of GBX 2,434. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73.

Johnson Matthey News Roundup

Here are the key news stories impacting Johnson Matthey this week:

• Positive Sentiment: Company insider Liam Condon bought 5,226 shares at GBX 1,923 (≈£100.5k), signalling management buying after the sell‑off — a modest confidence cue for investors. Insider Purchase
• Neutral Sentiment: Deal confirmed: Johnson Matthey will sell its Catalyst Technologies unit to Honeywell for approximately £1.3bn — the transaction proceeds will reduce group exposure and fund strategy, but the final economics were weakened by the price revision. Deal Announcement
• Negative Sentiment: Johnson Matthey accepted a roughly 26% reduction in the sale price for the Catalyst unit (a ~£475m cut), attributed to the unit underperforming — this directly reduces expected cash proceeds and upside from the disposal. Price Cut Report
• Negative Sentiment: Analyst reaction: J.P. Morgan cut its rating on JMAT to “neutral” following the £475m reduction in the deal price, increasing downside risk from lower cash proceeds and weaker near‑term earnings visibility. Analyst Downgrade
• Negative Sentiment: Market impact: Shares plunged roughly 15% as investors priced in the lower sale proceeds and greater execution risk for the Catalyst unit; volatility and lower liquidity can persist while the consequences for group cash and margin are re‑assessed. Share Price Reaction

Analyst Ratings Changes

Several brokerages recently issued reports on JMAT. Deutsche Bank Aktiengesellschaft boosted their price objective on Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the company a “buy” rating in a research report on Wednesday, January 21st. Berenberg Bank cut their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating on the stock in a research report on Tuesday, November 25th. Finally, Panmure Gordon restated a “buy” rating and set a GBX 2,370 price objective on shares of Johnson Matthey in a research note on Monday, November 24th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 2,268.

Johnson Matthey Company Profile

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.